Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2004
04/21/2004CN1146540C Novel compound with analgesic effect and use thereof
04/20/2004US6723859 Chromene compound
04/20/2004US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent
04/20/2004US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis
04/20/2004US6723725 Indole derivatives
04/20/2004US6723722 Acylhydrazine derivatives, their production and use
04/20/2004US6723720 Pesticidal triazine-derivatives
04/20/2004US6723718 Substituted α, β-anellated butyrolactones
04/20/2004US6723711 Vascular cell adhesion molecules and fibronectins; asthma, multiple sclerosis, arthritis, inflammatory bowel disease, contact hypersensitivity, cardiac allograft rejection and diabetes treatment
04/20/2004US6723445 Organic light-emitting devices
04/15/2004WO2004031401A2 Novel tyrosine kinases inhibitors
04/15/2004WO2004031384A1 Mouse-origin proteins forming domain or use thereof
04/15/2004WO2004031203A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
04/15/2004WO2004031182A1 Piperazine derivatives and methods of use
04/15/2004WO2004031181A1 Sulfonamide derivatives as antipsychotic agents
04/15/2004WO2004031176A2 Delta1 pyrrolines used as pesticides
04/15/2004WO2004031174A1 Imidazol-1-ylmethyl pyridazine derivatives
04/15/2004WO2004031172A1 Piperidine derivatives as ccr5 inhibitors
04/15/2004WO2004031159A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
04/15/2004WO2004031145A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
04/15/2004WO2004009558A3 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations
04/15/2004WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
04/15/2004US20040073048 Antitumor agents; anticancer agents; leukemia therapy; using metal alkoxide
04/15/2004US20040073047 Preparation of substituted isoserine esters using beta-lactams and metal or ammonium alkoxides
04/15/2004US20040073036 Substituted alkyl amido piperidines
04/15/2004US20040073026 Cyclic protein tyrosine kinase inhibitors
04/15/2004US20040072907 Antipicornaviral compounds, compositions containing them, and methods for their use
04/15/2004US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
04/15/2004US20040072888 Administering pyrazoloanthrone compound
04/15/2004US20040072887 Using 1,2,4-triazole compound
04/15/2004US20040072881 Dietetics; osteoporosis; muscular disorders
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072872 C10 ester substituted taxanes
04/15/2004US20040072871 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them
04/15/2004US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents
04/15/2004US20040072860 Piperazin-2-one amides as inhibitors of factor xa
04/15/2004US20040072844 2,4-Substituted indoles and methods of use
04/15/2004US20040072839 1-Phenylalkylpiperazines
04/15/2004US20040072828 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
04/15/2004US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents
04/15/2004US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
04/15/2004US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases
04/15/2004US20040072692 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines
04/15/2004DE10257188B3 Preparation of meso-substituted cyanine dye, for radiation-sensitive coating, e.g. for making printing plate, printed circuit boards or DVD, from 2-halo-cyclo-pentene or -hexene-dianil involves 1-stage introduction of end and meso-groups
04/15/2004CA2501243A1 Piperidine derivatives as ccr5 inhibitors
04/15/2004CA2500883A1 Mouse-origin proteins forming domain or use thereof
04/15/2004CA2499736A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
04/15/2004CA2499732A1 Piperazine derivatives and methods of use
04/15/2004CA2495698A1 Imidazol-1-ylmethyl pyridazine derivatives
04/14/2004EP1408038A2 Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase
04/14/2004EP1408027A1 DIAMINE DERIVATIVE,PROCESS FOR PRODUCING THE SAME, AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT
04/14/2004EP1406900A1 Novel compounds, their preparation and use
04/14/2004EP1406896A1 Atereoselective method for the preparation of nucleoside analogues
04/14/2004EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
04/14/2004EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
04/14/2004EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin
04/14/2004EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
04/14/2004EP1406877A1 Heterocyclic amines for the treatment of conditions associated with gsk-3
04/14/2004EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression
04/14/2004EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/14/2004EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
04/14/2004EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
04/14/2004EP1406632A2 Substituted 3-aryl-5-aryl- 1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
04/14/2004EP1406628A1 Tetrahydroquinoline derivatives
04/14/2004EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors
04/14/2004EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
04/14/2004EP1406618A2 Use of nk-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury
04/14/2004EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
04/14/2004EP1131297B1 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors
04/14/2004EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
04/14/2004EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
04/14/2004CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor
04/14/2004CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives
04/14/2004CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
04/14/2004CN1145616C Novel amino-triazole compound, its preparation method and drug composition containing them
04/14/2004CN1145612C New 1-aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them
04/13/2004US6720425 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
04/13/2004US6720351 1h-indole-2-carboxylic acid (2-(benzyl(methyl)amino) -2-oxo-1-phenylethyl)amides; triamide microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) inhibitors; obesity; antilipemic agents
04/13/2004US6720343 (((4-(3-thien-2-yl-1,2,4-oxadiazol-5-yl)phenyl)sulfonyl) amino)acetic acid, optionally substituted; selective matrix metalloprotease (mmp-2) inhibition; low protein binding, high blood concentration, no p-450 inhibition
04/13/2004US6720339 Such as n-phenyl-4-oxo-6,6-dimethyl-4,5,6,7-tetrahydro-1h-indole-3-carboxamide; for diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and for memory enhancement
04/13/2004US6720336 4,4-biarylpiperidine derivatives
04/13/2004US6720335 Sulfonamide inhibitors of aspartyl protease
04/13/2004US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
04/13/2004US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion)
04/13/2004US6720325 CCR5 antagonists useful for treating aids
04/13/2004US6720320 Phenoxypropylamine compounds
04/13/2004US6720317 Inhibitors of factor Xa
04/08/2004WO2004029026A1 Pyridine derivatives as cb2 receptor modulators
04/08/2004WO2004028530A1 N-substituted heterocyclic amines as modulators of chemokine receptor activity
04/08/2004WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
04/08/2004WO2004016741A3 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
04/08/2004WO2004016604A3 Azabicyclic compounds are central nervous system active agents
04/08/2004WO2004011454A3 Quinolyl propyl piperidine derivatives, preparation method and intermediates and compositions containing same
04/08/2004WO2003106452A3 Antagonists of melanin concentrating hormone receptor
04/08/2004WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
04/08/2004WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
04/08/2004WO2003051276B1 Therapeutic heterocycles
04/08/2004WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
04/08/2004US20040068122 Delta1-pyrrolines used as pesticides
04/08/2004US20040068118 Conjugated aromatic compounds with a pyridine substituent